Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance

C Van Els, J D'amaro, J Pool, E Blokland, A Bakker… - Immunogenetics, 1992 - Springer
C Van Els, J D'amaro, J Pool, E Blokland, A Bakker, PJ Van Elsen, JJ Van Rood, E Goulmy
Immunogenetics, 1992Springer
Minor Histocompatibility (mH) antigens are polymorphic endogenously synthesized products
that can be recognized by alloreactive T cells in the context of major histocompatibility
complex molecules. In transplant situations where tissue donor and recipient are matched
for HLA, mH antigens may trigger strong cellular immune responses. To gain insight into the
polymorphism of mH antigens we studied their frequencies in the healthy population. Five
HLA class I restricted mH antigens recognized by distinct cytotoxic T-cell (CTL) clones were …
Abstract
Minor Histocompatibility (mH) antigens are polymorphic endogenously synthesized products that can be recognized by alloreactive T cells in the context of major histocompatibility complex molecules. In transplant situations where tissue donor and recipient are matched for HLA, mH antigens may trigger strong cellular immune responses. To gain insight into the polymorphism of mH antigens we studied their frequencies in the healthy population. Five HLA class I restricted mH antigens recognized by distinct cytotoxic T-cell (CTL) clones were used in the population genetic analysis consisting of a panel (N=100) of HLA typed target cells. Three mH antigens showed phenotype frequencies of 69% or higher, this contrasted the frequencies of two other mH antigens with 16 and 7% respectively. To gain insight into the “functional” polymorphism of the T-cell response to mH antigens, we analyzed the specificity of CTL clones within individuals. Three out of five individuals investigated shared a CTL response to one single HLA-A2 restricted mH antigen. These results indicate limited allelic polymorphism for some mH antigens in the healthy population and are suggestive of the existence of immunodominant human mH antigens.
Springer